Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Int J Clin Pharm

Search In Journal Title:

Abbravation: International Journal of Clinical Pharmacy

Search In Journal Abbravation:

Publisher

Springer Netherlands

Search In Publisher:

DOI

10.1007/s00122-001-0816-x

Search In DOI:

ISSN

2210-7711

Search In ISSN:
Search In Title Of Papers:

Paediatric adverse drug reactions following use of

Authors: Lise Aagaard Ebba Holme Hansen
Publish Date: 2014/10/07
Volume: 36, Issue: 6, Pages: 1222-1229
PDF Link

Abstract

Background Information about safety issues from use of asthma medications in children is limited Spontaneous adverse drug reaction ADR reports can provide information about serious and rarely occurring ADRs in children Objective To characterize paediatric ADRs reported for asthma medications licensed for paediatric use Setting Spontaneous ADR reports located in the European ADR database EudraVigilance Method ADRs reported for asthma medications licensed for paediatric use from 2007 to 2011 were analysed The included substances were beclometasone budesonide fenoterol fluticasone formoterol mometasone montelukast salbutamol and terbutaline and the combinations of budesonide/formoterol fenoterol/ipratropium and fluticasone/salmeterol Main outcome measures Reported ADRs were categorized with respect to distribution on age sex type and seriousness of reported ADRs medications and type of reporter The unit of analysis was one ADR Results We located 326 spontaneous reports corresponding to 774 ADRs for the included asthma medications Approximately 85  of reported ADRs were serious including six fatal cases In total 57  of ADRs were reported for boys One quarter of all ADRs occurred in children up to 1 year of age Physicians reported the majority of ADRs Across medicines the majority of reported ADRs were of the type “psychiatric disorders” 13  of total ADRs followed by “respiratory thoracic and mediastinal disorders” 10  of total ADRs and “skin and subcutaneous disorders” 9  of total ADRs The largest number of ADRs was reported for budesonide 21  of total ADRs followed by salbutamol 20  of total ADRs and fluticasone 19  of total ADRs For salbutamol the largest numbers of serious ADRs were “tachycardia” “accidental exposure/incorrect dose administered” and “respiratory failure” Conclusion Only a few ADRs from use of asthma medications in children were identified in the EudraVigilance ADR database but a large majority of these were serious including fatal cases


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. ESCP–SFPC international workshop acquisition of pharmaceutical skills: simulation, serious games, innovative approaches 22–23 June 2015, Nice, France
  2. Frequency, types and severity of medication use-related problems among medical outpatients in Nigeria
  3. Communication between community and hospital pharmacists: impact on medication reconciliation at admission
  4. The effect of medication reconciliation in elderly patients at hospital discharge
  5. Sources and magnitude of error in preparing morphine infusions for nurse–patient controlled analgesia in a UK paediatric hospital
  6. Mental health pharmacists views on shared decision-making for antipsychotics in serious mental illness
  7. Correlation between prescribed daily dose, seizure freedom and defined daily dose in antiepileptic drug treatment
  8. Editorial
  9. Erratum to: Assessment of pharmacist’s recommendation of non-prescription medicines in Brazil: a simulated patient study
  10. Building hospital pharmacy practice research capacity in Qatar: a cross-sectional survey of hospital pharmacists
  11. Pharmacist prescribing in Northern Ireland: a quantitative assessment
  12. Intravenous phenytoin: a retrospective analysis of Bayesian forecasting versus conventional dosing in patients
  13. Evaluation of drug–drug interaction screening software combined with pharmacist intervention
  14. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial
  15. Anticoagulation control of pharmacist-managed collaborative care versus usual care in Thailand
  16. Analysis of drug-related problems in three departments of a German University hospital
  17. Development of consensus guidance to facilitate service redesign around pharmacist prescribing in UK hospital practice

Search Result: